AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 153 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,084,000 | +27.1% | 182,709 | +36.0% | 0.05% | +13.0% |
| Q4 2018 | $3,213,000 | -43.4% | 134,332 | -35.5% | 0.05% | -37.0% |
| Q3 2018 | $5,679,000 | -14.4% | 208,182 | -15.6% | 0.07% | -20.7% |
| Q2 2018 | $6,635,000 | +69.1% | 246,749 | +100.1% | 0.09% | +53.3% |
| Q1 2018 | $3,924,000 | -16.1% | 123,283 | -0.3% | 0.06% | -11.8% |
| Q4 2017 | $4,678,000 | -18.3% | 123,700 | -46.4% | 0.07% | -16.0% |
| Q3 2017 | $5,724,000 | +11.9% | 230,900 | -7.2% | 0.08% | +3.8% |
| Q2 2017 | $5,115,000 | +25.2% | 248,800 | +32.3% | 0.08% | +13.0% |
| Q1 2017 | $4,087,000 | – | 188,100 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |